Askoxylakis, Vasileios
Badeaux, Mark
Roberge, Sylvie
Batista, Ana
Kirkpatrick, Ned
Snuderl, Matija
Amoozgar, Zohreh
Seano, Giorgio http://orcid.org/0000-0002-7294-302X
Ferraro, Gino B
Chatterjee, Sampurna
Xu, Lei
Fukumura, Dai
Duda, Dan G
Jain, Rakesh K
Article History
First Online: 5 October 2017
Competing interests
: R.K.J. received consultant fees from Enlight, Ophthotech, Pfizer, SPARC and SynDevRx, owns equity in Enlight, Ophthotech, SynDevRx and XTuit, and serves on the Board of Directors of XTuit and the Boards of Trustees of Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund, and Tekla World Healthcare Fund. No funding or reagents from these companies were used in this study.